Azur Sues Barr Over Plan To Make Generic FazaClo
CIMA Labs Inc. and Irish drugmaker Azur Pharma Ltd. have sued generics rival Barr Pharmaceuticals Inc. over its plan to make a generic version of Azur's anti-psychotic drug FazaClo, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article